Edgen Stock·Sep 19 2025, 00:44戻る
戻る
Absci Aligns with Oracle and AMD for AI-Driven Drug Discovery, Market Assesses Valuation and Growth Trajectory
Edgen Stock·Sep 19 2025, 00:44
[1] Absci (ABSI) Valuation in Focus Following Partnership With Oracle Cloud and AMD for AI Drug Discovery[2] Absci (ABSI) Partners with Oracle and AMD for AI-Enhanced Drug Discovery - GuruFocus[3] Needham, known as a 'biotech stock picker,' is betting on this leader in 'AI + drug discovery,' forecasting a 68% surge in its stock price.